drugset / Trial / NCT03001635

Role of Oxytocin in Myocardial Infarction

NCT03001635

Phase 2/3 Unknown 52 enrolled Sheba Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

60 patients admitted to this ICCU at the Sheba medical Center will be randomly divided in to 2 groups. one group will receive the conventional treatment while the second group will receive the conventional treatment plus oxytocin infusion for 48 hours. all participants will undergo echo and cMRI during hospitalization.

Timeline

Start
2017-01
Primary completion
2018-12
Completion

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 10 iu Other

Indications